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Background: Despite the high efficacy of catheter ablation of ventricular tachycardia (VT) in patients with arrhythmogenic right ventricular 
dysplasia (ARVD),in some patients, conventional endocardial ablation is ineffective. These failures couldbe explained by the presence of epicardial 
arrhythmogenic substrate. In these cases, a percutaneous epicardial ablation may be required.
Methods: Seventeen ARVD pediatric patients (mean age of 14 ± 4years) in whom a percutaneous epicardial RF ablation of VT was attempted were 
included in this retrospective analysis.
Results: A total of 20 mappable, hemodynamically stable, monomorphic VTs were induced (2 macro-reentrant and 18 focal). All patients underwent 
RV epicardial VT ablation. At the end of the procedure, 16 (94.1%) of the 17 patients had no inducible VT. Pericardial effusion occurred in 4 patients 
(23.5%), with 1 (5.9%) patient having tamponade that required percutaneous pericardial drainage. During a mean follow-up of 26 ± 15 (range 
6-42) months, 12 (70.6%) patients remained free of any episodes of VT. All patients with successful RF ablation were free from any antiarrhythmic 
drugs. There were no deaths during the follow-up period. Recurrences of VT were recorded in 5 (29.4%) patients.
Conclusions: Percutaneous epicardial catheter ablation is feasible and relatively safe in a pediatric ARVD patients with recurrent VT in whom 
conventional endocardial ablation failed. 
